Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse
Leukemia ( IF 12.8 ) Pub Date : , DOI: 10.1038/leu.2017.285 P Boddu , J Jorgensen , H Kantarjian , G Borthakur , T Kadia , N Daver , Y Alvarado , N Pemmaraju , P Bose , K Naqvi , M Yilmaz , S Pierce , M Brandt , C D DiNardo , E J Jabbour , M Konopleva , G Garcia-Manero , J Cortes , F Ravandi
Leukemia ( IF 12.8 ) Pub Date : , DOI: 10.1038/leu.2017.285 P Boddu , J Jorgensen , H Kantarjian , G Borthakur , T Kadia , N Daver , Y Alvarado , N Pemmaraju , P Bose , K Naqvi , M Yilmaz , S Pierce , M Brandt , C D DiNardo , E J Jabbour , M Konopleva , G Garcia-Manero , J Cortes , F Ravandi
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse
中文翻译:
低甲基化药物治疗后,老年AML患者达到最小残留病态阴性的可能性降低了复发的风险
低甲基化药物治疗后,老年AML患者达到最小残留病态阴性的可能性降低了复发的风险
更新日期:2017-09-19
Leukemia, Published online: 18 September 2017; doi:10.1038/leu.2017.285
中文翻译:
低甲基化药物治疗后,老年AML患者达到最小残留病态阴性的可能性降低了复发的风险
低甲基化药物治疗后,老年AML患者达到最小残留病态阴性的可能性降低了复发的风险
白血病,在线发布:2017年9月18日; doi:10.1038 / leu.2017.285